A group of oncologists from across the world, including Dr. Zach Klaassen of the Georgia Cancer Center, came together to develop guidelines for patients diagnosed with prostate, testicular and other genitourinary cancers during the COVID-19 pandemic.
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed...
MCG scientists hope non-invasive and better tests that measure a gene variant commonly found in bladder cancer could help improve patient outcomes.
It has long been known that African Americans die at higher rates from bladder cancer than do European Americans. New research looking at differences in the way tumor cells in African American patients metabolize proteins and nutrients could be the...
While it’s widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread. “Today we actually propose that blood...
Julie Cole, a bladder cancer patient being treated at the Georgia Cancer Center, was willing to take a risk when her life depended on it. Cole, along with Dr. Jigarkumar Parikh, decided to add a second immunotherapy drug and radiation to try and...
Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report. Genitourinary cancers – prostate, bladder, kidney, testis, and penile...
Augusta University
